MENU
TCRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
TScan Therapeutics (TCRX) Ownership - Who owns TScan Therapeutics?
Profile
Industry
N/A
Address
830 Winter Street
Phone
+1 857 399-9500
Employees
154
Web
https://www.tscan.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
158.51M
P/E Ratio
N/A
Total Cash
271.12M
Projected Growth
N/A
Total Debt
90.36M
Revenue
9.36M
Risk (Beta)
0.78
Dividend Yield
N/A
Total Cash/Share
5.08
Total Debt/Equity
N/A
Revenue/Share
0.09 USD as % of share price
Fundamentals
TCRX
Capitalization
159M
P/E Ratio
N/A
Risk (Beta)
0.78
Dividend Yield
N/A
Total Cash
271M
Total Cash/Share
5.08
Total Debt
90.4M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.09%
Revenue
9.36M
ROE
N/A
Book Value
229M
P/B Ratio
0.67
Cash Flow
N/A
Earnings
-0.95
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6K
Current Ratio
9.56
Current Revenue Per Employee
5271.36
Dividends Per Share - Security
N/A
EBITDA
-102.91M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-34.81
Shares Held By Institutions
240M
Shares Outstanding - Current
53.4M
Total Liabilities
119M
Total Volume MTD
N/A
Value
1
Gain YTD
-49.057
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
830 Winter Street
Phone
+1 857 399-9500
Employees
154
Web
https://www.tscan.com